117 - Influenza Vaccines

10/4/2019

10:30 AM - 11:45 AM

Room: Walter E. Washington Convention Center, 146 ABC

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-363-L06-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe best practices in use of influenza vaccines
examine advances that will inform future vaccine development

Presentations:

10:30 AM - 10:55 AM
939 - Influenza Vaccine and Indirect Protection: Optimizing the Impact of Influenza Vaccine
Meagan C. Fitzpatrick, PhD – Center for Vaccine Development and Global Health, University of Maryland School of Medicine
10:55 AM - 11:20 AM
940 - Current Influenza Vaccines: Are We Ready for Different Vaccines for Different Populations?
Kathy Neuzil, MD, MPH – University of Maryland School of Medicine
11:20 AM - 11:45 AM
941 - New Insights On Correlates of Protection and the Development of Broadly Protective Influenza Vaccines
Matthew J. Memoli, MD, MS – National Institutes of Health

Moderator(s)

Kathy Neuzil, MD, MPH

Director
University of Maryland School of Medicine
Baltimore, Maryland

Disclosure: Nothing to disclose
Andrew Pavia, MD

George and Esther Gross Presidential Professor Chief, Division of Pediatric Infectious Diseases
University of Utah
Salt Lake City, UT

Speaker(s)

Meagan Fitzpatrick, PhD

Assistant Professor
Center for Vaccine Development and Global Health, University of Maryland School of Medicine
Baltimore, MD

Disclosure: Sanofi Pasteur: Consultant
Matthew Memoli, MD, MS

Senior Clinician, Director LID Clinical Studies Unit
National Institutes of Health
Bethesda, MD

Disclosure: Nothing to disclose
Kathy Neuzil, MD, MPH

Director
University of Maryland School of Medicine
Baltimore, Maryland